STOCK TITAN

ECS Wins IT Support Services Blanket Purchase Agreement With the National Institutes of Health, Expected Spend of $1.1B

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Positive)
Tags

ECS, an ASGN brand, has been awarded a prime contract on the National Institute of Allergy and Infectious Diseases (NIAID) Enabling and Advancing Technologies (NEAT) blanket purchase agreement. This five-year, multi-award contract represents new work for ECS and is expected to have a spend of $1.1 billion. ECS will provide a wide range of IT support services to NIAID, including cybersecurity, AI, and data management and analytics.

The contract supports NIAID's mission of conducting research to understand, treat, and prevent infectious, immunologic, and allergic diseases. ECS aims to enhance NIAID's scientific research through IT innovation and modernization efforts.

ECS, un marchio di ASGN, ha ricevuto un contratto principale sul National Institute of Allergy and Infectious Diseases (NIAID) Enabling and Advancing Technologies (NEAT) accordo quadro di acquisto. Questo contratto multi-premio della durata di cinque anni rappresenta un nuovo impegno per ECS e si prevede che avrà una spesa di 1,1 miliardi di dollari. ECS fornirà una vasta gamma di servizi di supporto IT a NIAID, inclusi sicurezza informatica, intelligenza artificiale e gestione e analisi dei dati.

Il contratto sostiene la missione di NIAID di condurre ricerche per comprendere, trattare e prevenire malattie infettive, immunologiche e allergiche. ECS mira a migliorare la ricerca scientifica di NIAID attraverso innovazione e modernizzazione IT.

ECS, una marca de ASGN, ha sido adjudicada un contrato principal en el National Institute of Allergy and Infectious Diseases (NIAID) Enabling and Advancing Technologies (NEAT) acuerdo de compra general. Este contrato de cinco años y múltiples adjudicaciones representa un nuevo trabajo para ECS y se espera que tenga un gasto de 1.1 mil millones de dólares. ECS proporcionará una amplia gama de servicios de soporte de TI a NIAID, incluyendo ciberseguridad, inteligencia artificial y gestión y análisis de datos.

El contrato apoya la misión de NIAID de realizar investigaciones para comprender, tratar y prevenir enfermedades infecciosas, inmunológicas y alérgicas. ECS tiene como objetivo mejorar la investigación científica de NIAID a través de la innovación y los esfuerzos de modernización de TI.

ECS는 ASGN 브랜드로 국립 알레르기 및 전염병 연구소(NIAID) 지원 및 발전 기술(NEAT)의 blanket 구매 계약에서 주요 계약을 체결했습니다. 이 5년 간의 다수 수상 계약은 ECS에 대한 새로운 작업을 나타내며 11억 달러의 지출이 예상됩니다. ECS는 NIAID에 사이버 보안, 인공지능, 데이터 관리 및 분석을 포함한 다양한 IT 지원 서비스를 제공합니다.

이 계약은 NIAID의 전염병, 면역병 및 알레르기 질환을 이해하고 치료하며 예방하기 위한 연구 수행 임무를 지원합니다. ECS는 IT 혁신 및 현대화 노력을 통해 NIAID의 과학 연구를 향상시키는 것을 목표로 하고 있습니다.

ECS, une marque d'ASGN, a été attribuée un contrat principal dans le cadre de l'accord de National Institute of Allergy and Infectious Diseases (NIAID) Enabling and Advancing Technologies (NEAT). Ce contrat de cinq ans, à multiples attributions représente un nouveau travail pour ECS et devrait avoir des dépenses de 1,1 milliard de dollars. ECS fournira une large gamme de services de support informatique à NIAID, y compris la cybersécurité, l'IA, et la gestion et l'analyse des données.

Ce contrat soutient la mission de NIAID de mener des recherches pour comprendre, traiter et prévenir les maladies infectieuses, immunologiques et allergiques. ECS vise à améliorer la recherche scientifique de NIAID grâce à l'innovation informatique et aux efforts de modernisation.

ECS, eine Marke von ASGN, hat einen Hauptvertrag im Rahmen des National Institute of Allergy and Infectious Diseases (NIAID) Enabling and Advancing Technologies (NEAT) Rahmenkaufvertrags erhalten. Dieser fünfjährige, mehrfach ausgezeichnete Vertrag stellt eine neue Aufgabe für ECS dar und wird voraussichtlich ein Ausgabenvolumen von 1,1 Milliarden Dollar haben. ECS wird NIAID eine breite Palette von IT-Supportdiensten anbieten, einschließlich Cybersecurity, KI sowie Datenmanagement und -analyse.

Der Vertrag unterstützt die Mission von NIAID, Forschung zu betreiben, um infektiöse, immunologische und allergische Erkrankungen zu verstehen, zu behandeln und zu verhindern. ECS hat das Ziel, die wissenschaftliche Forschung von NIAID durch IT-Innovation und Modernisierungsmaßnahmen zu verbessern.

Positive
  • Awarded prime contractor status on a $1.1 billion contract with NIAID
  • Five-year contract represents new business for ECS
  • Expands ECS's presence within NIH, building on existing partnerships
  • Opportunity to provide a wide range of IT services, including cybersecurity, AI, and data analytics
Negative
  • None.

This $1.1 billion contract win is a significant development for ECS and its parent company ASGN. The five-year blanket purchase agreement with the National Institute of Allergy and Infectious Diseases (NIAID) represents new business for ECS, potentially boosting its revenue and market position in the government IT services sector. The contract's focus on cutting-edge technologies like AI, cybersecurity and data analytics aligns well with high-growth areas in the IT industry. For investors, this $1.1 billion expected spend over five years translates to an average of $220 million annually, which could significantly impact ECS's financial performance. However, as a multi-award contract, the actual revenue will depend on ECS's ability to secure task orders against competitors.

ECS's win in this NIAID contract is noteworthy for its technological breadth. The company will be delivering a comprehensive range of IT services, including cyber infrastructure, software engineering, AI and data management. This aligns with the trend of government agencies seeking integrated solutions rather than piecemeal services. The focus on cybersecurity is particularly important given the sensitive nature of NIAID's work. ECS's ability to provide these advanced services suggests a strong technological capability, which could position them well for future contracts in both public and private sectors. The emphasis on AI and data analytics also indicates that NIAID is looking to leverage these technologies to accelerate research and improve disease prevention and treatment strategies.

This contract with NIAID has significant implications for medical research. NIAID's mission to conduct basic and applied research on infectious, immunologic and allergic diseases is critical, especially in light of recent global health challenges. ECS's IT support will likely accelerate NIAID's research capabilities, potentially leading to faster discoveries and more efficient responses to public health crises. The integration of AI and advanced data analytics into NIAID's IT infrastructure could enhance the institute's ability to process vast amounts of research data, identify patterns and generate insights that might not be apparent through traditional methods. This could lead to breakthroughs in understanding diseases and developing new treatments, ultimately benefiting public health on a global scale.

Company to deliver the entire range of IT support services to the NIAID, including cybersecurity, AI, and data management and analytics

FAIRFAX, Va.--(BUSINESS WIRE)-- ECS, an IT systems integrator focused on data and AI, cybersecurity, and enterprise transformation solutions, and an ASGN (NYSE: ASGN) brand, has been named a prime contractor on the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) Enabling and Advancing Technologies (NEAT) blanket purchase agreement. This five-year, multi-award contract vehicle with the NIH, which represents new work for ECS, positions the company to deliver the entire range of IT support services to the NIAID, including cyber infrastructure, software engineering, cybersecurity, AI, and data management and analytics solutions.

ECS currently performs business operations support and analytical support services for the National Heart, Lung, and Blood Institute (NHLBI) and provides cybersecurity services to the NIH Information Security and Assurance Office (ISAO) within the NIH Center for Information Technology (CIT).

The new work, overseen by the NIH NIAID Office of Cyber Infrastructure and Computational Biology (OCICB), will support the NIAID’s mission of conducting basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. NIAID expects to spend nearly $1.1 billion via this contract vehicle over the next five years.

“Building on our decades-long partnership with the NIH, this award represents an important next step in IT innovation and advancement for NIAID’s globally impactful mission,” said John Heneghan, president of ECS. “ECS is proud to support NIAID’s efforts to lead the world in scientific research that will improve our understanding, diagnosis, and treatment of infectious, immunologic, and allergic diseases.”

“With this award, NIAID will enhance scientific research and development through innovation and the augmentation of its IT ecosystem, leveraging the best of cutting-edge technologies, platforms, and access to top IT professional talent,” said Asad Akhtar, vice president of Health and Human Services at ECS. “ECS has demonstrated our ability to support NIH’s most critical modernization efforts, and we are excited to partner with NIAID to deliver on our core capabilities of software engineering, infrastructure, and data management and analytics. We look forward to delivering IT support services across the Institute and helping to safeguard the public from outbreaks, diseases, and other public health crises.”

About ECS

ECS, part of ASGN Incorporated’s Federal Government Segment, delivers advanced solutions in cybersecurity, data and artificial intelligence (AI), cloud, application and IT modernization, science, and engineering. The company solves critical, complex challenges for customers across the U.S. public sector, including defense and intelligence organizations. ECS maintains partnerships with leading cloud, cybersecurity, and AI/ML providers and holds specialized certifications in their technologies. Headquartered in Fairfax, Virginia, ECS has nearly 4,000 employees throughout the United States. For more information, visit ECStech.com.

About ASGN Incorporated

ASGN Incorporated (NYSE: ASGN) is a leading provider of IT services and solutions across the commercial and government sectors. ASGN helps corporate enterprises and government organizations develop, implement, and operate critical IT and business solutions through its integrated offerings. For more information, please visit asgn.com.

Safe Harbor

Certain statements made in this news release are “forward-looking statements” within the meaning of Section 27A of the Securities Exchange Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and involve a high degree of risk and uncertainty. Forward-looking statements include statements regarding our anticipated financial and operating performance. All statements in this news release, other than those setting forth strictly historical information, are forward-looking statements. Forward-looking statements are not guarantees of future performance and actual results might differ materially. For a full list of risks and discussion of forward-looking statements, please see our Annual Report on Form 10-K for the year ended December 31, 2023, as filed with the SEC on February 23, 2024. We specifically disclaim any intention or duty to update any forward-looking statements contained in this news release.

Shab Nassirpour, ECS Vice President of Marketing and Communications

(703) 270-1540

Shab.Nassirpour@ECStech.com



Kimberly Esterkin, Vice President, Investor Relations, ASGN

kimberly.esterkin@asgn.com

Source: ECS IR

FAQ

What is the value of the NIAID NEAT contract awarded to ECS?

The NIAID NEAT contract awarded to ECS has an expected spend of $1.1 billion over five years.

What types of services will ECS provide under the NIAID contract?

ECS will provide a range of IT support services, including cyber infrastructure, software engineering, cybersecurity, AI, and data management and analytics solutions.

How long is the duration of the NIAID NEAT contract awarded to ECS?

The NIAID NEAT contract awarded to ECS is a five-year, multi-award contract vehicle.

How does this contract impact ASGN's (NYSE: ASGN) business with NIH?

This contract expands ASGN's business with NIH, as ECS (an ASGN brand) gains new work with NIAID in addition to its existing partnerships with other NIH institutes.

ASGN Incorporated

NYSE:ASGN

ASGN Rankings

ASGN Latest News

ASGN Stock Data

4.15B
44.80M
3.31%
99.32%
3.23%
Information Technology Services
Services-help Supply Services
Link
United States of America
GLEN ALLEN